Brought to you by 
Series A raises €49mm for Movetis NV
23 Oct 2009
Executive Summary
Movetis NV (therapeutics for gastrointestinal disorders) brought in €49mm ($64mm) with its Series A financing. Sofinnova Partners and Life Sciences Partners led the round and were joined by Sofinnova Ventures, KBC, GIMV, Quest for Growth, and BIP Investment Partners.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Spin-Off
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series A raises €49mm for Movetis NV
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice